OR WAIT null SECS
May 12, 2023
Amid drug pricing blame game, Congress advancing a range of reform efforts to manage and curb pharmacy benefit manager practices.
March 24, 2023
Amid continued tussling over drug costs, a new working group will review the government’s authority to revoke licenses for medical products.
March 07, 2023
Latest investigation signals more scrutiny of pharmacy benefit managers and their role in treatment cost and coverage.
March 11, 2022
From supply-chain and clinical-trial disruptions in Ukraine and Russia, to decisions to halt investment or maintain operations, global implications for industry and pharmaceutical production are immense.
January 06, 2022
Pandemic notwithstanding, the agency maintained a steady pace in 2021 in clearing important new therapies, including new vaccines and drugs for Covid
December 07, 2021
Biden touts provisions administration believes can curb spending on pharmaceuticals